US Stock MarketDetailed Quotes

IMAB I-Mab

Watchlist
  • 1.020
  • -0.040-3.81%
Trading Dec 12 10:50 ET
83.10MMarket Cap-1.06P/E (TTM)

About I-Mab Company

I-Mab operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Rockville, MD.

Company Profile

SymbolIMAB
Company NameI-Mab
Listing DateJan 17, 2020
Issue Price14.00
Founded2016
CEODr. Xi-Yong Sean Fu
MarketNASDAQ
Employees220
Securities TypeDR
ADS Ratio10.0 : 23.0
Fiscal Year Ends12-31
Address2440 Research Boulevard,Suite 400
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-240-745-6330
Websitehttp://www.i-mabbiopharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Xi-Yong Sean Fu
  • Chief Executive Officer and Director
  • --
  • Dr. Phillip Dennis, M.D.
  • Chief Medical Officer
  • --
  • Joseph Skelton
  • Chief Financial Officer
  • --
  • Wei Fu
  • Chairman of the Board
  • --
  • Chun Kwok Alan Au
  • Independent Director
  • --
  • Chia-hung Conor Yang
  • Independent Director
  • --
  • Lielie Zhang
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data